ET Awards for Corporate Excellence: Honouring India’s best and brightestGlittering ceremony on May 7, 2022
07 May, 2022, 02.12 PM IST
ET Awards: Serum CEO Poonawalla voted Biz Leader of the Year while Infosys declared top companyFreshworks founder and CEO Girish Mathrubootham walked away with the coveted Entrepreneur of the Year award, while Cipla's executive vice-c...
28 Mar, 2022, 01.18 PM IST
COVID-19: Corbevax, Covovax, Molnupiravir approved for emergency useUnion Health Minister Mansukh Mandaviya on Tuesday said that the Central Drug Authority CDSCO has approved the Serum Institute of India's C...
28 Dec, 2021, 12.13 PM IST
A game-changing pill and two new vaccines will bolster India's fight against Covid variantsThe recommendations have been sent to the Drug Controller General of India (DCGI), which will soon decide on their approval, people in the ...
28 Dec, 2021, 11.54 AM IST
Government panel recommends EUA for COVID-19 vaccines Covovax, Corbevax and anti-Covid pill molnupiravirThe SEC on COVID-19 of the CDSCO, which reviewed the emergency use authorisation (EUA) applications of Serum Institute of India (SII) for t...
28 Dec, 2021, 10.59 AM IST
India to play vital role in equitable distribution of COVID-19 vaccines around the world: Pharma industryAs the pandemic hit the world in 2020, Indian pharma industry rose to the occasion and was able to manufacture and maintain supply chains e...
27 Dec, 2020, 02.24 PM IST
Large pharma companies back appeal for TRIPS waiver for Covid-19 cure“We endorse the Indian government’s stand asking for a waiver of the TRIPS provisions to deal with the Covid-19 crisis. This is the time fo...
05 Oct, 2020, 06.58 AM IST
ETIG Analysis: Pharma companies involved in rolling out Covid-19 treatments face ESG implicationsMoody's Investor Services said in a report last week that the ongoing Covid-19 vaccine development globally comes with both positives as we...
15 Jul, 2020, 09.11 AM IST
COVID-19: Infections rise, so do vaccine trialsEver since the Covid-19 outbreak late last year, the world has been moving much faster with regards to working on a vaccine and a possible ...
06 Jun, 2020, 07.16 AM IST
Domestic pharmaceutical players eye Bharat Serums acquisitionThe two funds together hold a 23% stake and the remainder is with the Daftary family.
30 Aug, 2018, 10.07 AM IST
Cipla, Serum Institute launch Hepatitis B vaccineAs per Cipla's co-exclusive agreement with SII, the former will market the vaccine for adults while the latter will market it for adults an...
17 Feb, 2017, 05.45 PM IST
Cipla ties up with Serum Institute to sell vaccines in South AfricaCipla said it had agreed to an exclusive deal with Serum Institute to supply vaccines to South Africa, adding a new market to their partner...
08 Oct, 2015, 03.48 PM IST
Pharma companies blame archaic law for lack of swine flu drugs"Since the drug comes under Schedule X, there are various licences required to stock the medicines, which dissuades chemists to stock them,...
19 Feb, 2015, 05.55 AM IST
Cipla shares end nearly 4% higher post agreement with Serum InstituteCipla's stock surged 3.23 per cent to settle at Rs 618.60 on the BSE. In intra-day, it climbed 4.13 per cent to Rs 624.
20 Nov, 2014, 06.13 PM IST
Cipla Ltd to market Serum Institute's paediatric vaccines in EuropeCipla has launched multiple respiratory products in Europe this year, and launch of some key inhalers is expected in 2015.
20 Nov, 2014, 12.53 PM IST
- Govt curbs sale of flu drug Zanamivir
The government is set to put Zanamivir, the only swine flu drug that is freely available in the market, currently, under restricted sale ca...
29 Aug, 2009, 12.49 AM IST
- Govt to import 2 cr more pills to treat H1N1
With about 70% of its stock used up, the government will now procure two crore more pills of oseltamivir—the generic version of Swiss firm ...
11 Aug, 2009, 03.06 AM IST